Access our monthly newsletter and amplify your learning power by reading the latest from our scientists.
SFW Capital-Backed Pion’s Acquisition of BEE International Adds Next-Generation Emulsifying and Homogenization Technology to Broaden Its Product Portfolio
SFW Capital-Backed Pion’s Acquisition of Two Square Science Adds Sample Preparation and Remote Monitoring Technology to Augment Its Product Portfolio.
Pion Inc introduces a new solution for subcutaneous injection formulation development.
Pion showcases how our innovative instruments assist formulation scientists by providing richer, more relevant insights on dissolution, solubility, ionization and much more not easily accessible prior to clinical studies at AAPS PharmSci 360.
Pion, Inc. (“Pion”), a leading provider of analytical instrumentation for formulation development and quality control in the life sciences industry, has announced it is strengthening its commercial team with two key appointments.
Key Appointments Demonstrate Commitment to Unrivaled Customer Service
MA. November 16: Pion Inc, leading provider of analytical instruments that bridge the gap between in vitro experiments and in vivo outcomes launches the SCISSOR N3, its new Subcutaneous Injection Site Simulator.
Link to our YouTube Channel for access to all of our webinars and videos
Spotlight on Scissor & meet your Account Manager!
Read about upcoming seminars, FAQ's on the SiriusT3 and more!
Find link to miniDISS Profiler video and meet new members of the Pion team.
Read more about the SDi2!
Current subcutaneous testing protocols can exhibit extremely poor correlation between animal models and human outcomes and have a high cost and inherent variability associated with in-vivo models.
